Myriad Genetics Inc.

(MYGN) Trade

By |

Profile

Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.

Contact Information

Website: www.myriad.com
Email: sgleason@myriad.com
Main Phone: +1 801 584-3600
Address: 320 Wakara Way
State: UT
City / Town: Salt Lake City
Country: USA
Postal Code: 84108

Issuer Information

Exchange: NGS
CEO: Mark Christopher Capone
Employees: 2400
NAICS: In-Vitro Diagnostic Substance Manufacturing (325413)
$ 43.75 $ 0.93 (2.17%)
Last Price 43.75 Change $ 0.93 Change % 2.17 Tick N/A
Bid 40.10 Bid Size 100.00 Ask 43.99 Ask Size 100.00
Open 42.92 High 43.88 Low 42.54 Prev Close 42.82
Last Trade Volume 623,066 52 Wk Hi 44.31 52 Wk Low 23.28
Market Cap 3.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 69,906,818.00 EPS (TTM) 1.95 PE Ratio 22.00 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 20 84
Number of Buys 10 34
Number of Sells 10 50
Net Activity 0 393354
Last 10 Buys Shares
John T. Henderson 1,000
John T. Henderson 1,000
John T. Henderson 1,000
Mark Christopher Capone 1,000
Ralph L. Mcdade 1,000
John T. Henderson 1,000
Last 10 Sell Shares
Dennis H. Langer 1,000
Dennis H. Langer 1,000
Walter Gilbert 1,000
Dennis H. Langer 1,000
Dennis H. Langer 1,000
Walter Gilbert 1,000
Dennis H. Langer 1,000
Dennis H. Langer 1,000
Dennis H. Langer 1,000
Dennis H. Langer 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 45 45 45 45
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 34 34 34 34
Standard Deviation 7.13 7.13 7.13 7.13
Date of Most Recent Estimate 06/04/18 05/14/18 05/14/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 7 7 8 8
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 2
Mean Rec. 2.75 2.75 2.77 2.88